American College of Clinical Pharmacy
      Search      Cart
         

Institution Profile - MD Anderson Cancer Center

W-5126
Residency
PGY2
4
Andrea Landgraf Oholendt, Pharm.D., BCOP
MD Anderson Cancer Center
Oncology
1
ASHP
July 15
$60,000
Andrea Landgraf Oholendt, PharmD, BCOP
MD Anderson Cancer Center
1515 Holcombe Blvd.Unit 90
Houston, TX 77030
(713) 792-4552 (Phone)
anlandgr@mdanderson.org
http://www.mdanderson.org/pharmacy
Pharmacists completing the PGY2 Oncology Pharmacy Residency program at The University of Texas MD Anderson Cancer center will become competent and confident practitioners of oncology pharmacy practice. Residents will be accountable for achieving optimal drug therapy outcomes as an integral member of interdisciplinary health care teams while striving to improve the overall medication use process. They will exercise skill in oncology pharmacy operations, drug information, investigational pharmacy services, clinical research and writing, and providing education to health care professionals, patients, and the general public. Graduates from the program will be prepared to provide clinical pharmacy services for oncology, malignant hematology, and stem cell transplant patient populations in both the acute and ambulatory care settings.